| scholarly article | Q13442814 |
| P50 | author | Charleen T. Chu | Q42324219 |
| P2093 | author name string | Salvatore J Cherra | |
| Kirill Kiselyov | |||
| Aaron M Gusdon | |||
| Erin Steer | |||
| P2860 | cites work | Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. | Q21135493 |
| Guidelines for the use and interpretation of assays for monitoring autophagy | Q21996341 | ||
| Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. | Q42504276 | ||
| Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. | Q42790455 | ||
| Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2). | Q43141823 | ||
| Morphology, electrophysiology and functional input connectivity of pyramidal neurons characterizes a genuine layer va in the primary somatosensory cortex | Q46472848 | ||
| Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons. | Q46900848 | ||
| Spontaneous synchronous synaptic calcium transients in cultured cortical neurons | Q48402191 | ||
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level | Q48858572 | ||
| Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. | Q52073489 | ||
| Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assays. | Q54781213 | ||
| Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice | Q71860224 | ||
| Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity | Q22254785 | ||
| LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool | Q24292798 | ||
| Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression | Q24293587 | ||
| Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP | Q24293723 | ||
| PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 | Q24297155 | ||
| Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2) | Q24298459 | ||
| LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations | Q24306239 | ||
| Parkin is recruited selectively to impaired mitochondria and promotes their autophagy | Q24317471 | ||
| The familial Parkinsonism gene LRRK2 regulates neurite process morphology | Q24317613 | ||
| Localization of LRRK2 to membranous and vesicular structures in mammalian brain | Q24318643 | ||
| Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission | Q24320327 | ||
| The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro | Q24322792 | ||
| LRRK2 regulates synaptic vesicle endocytosis | Q24336523 | ||
| Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease | Q24336655 | ||
| Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity | Q24338647 | ||
| 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization | Q24339094 | ||
| LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
| Regulation of the autophagy protein LC3 by phosphorylation | Q24627351 | ||
| Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells | Q24651391 | ||
| LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model | Q24656256 | ||
| ATP13A2 regulates mitochondrial bioenergetics through macroautophagy | Q28116275 | ||
| Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology | Q28131833 | ||
| Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 | ||
| 'Rejuvenation' protects neurons in mouse models of Parkinson's disease | Q28305585 | ||
| Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 | Q28510145 | ||
| Pruning and loss of excitatory synapses by the parkin ubiquitin ligase | Q28576054 | ||
| Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease | Q28586694 | ||
| Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S | Q28589899 | ||
| Autophagy as a regulated pathway of cellular degradation | Q29547914 | ||
| Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy | Q29614178 | ||
| Chronic systemic pesticide exposure reproduces features of Parkinson's disease | Q29614763 | ||
| LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity | Q29615144 | ||
| The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses | Q29615239 | ||
| The PINK1/Parkin pathway regulates mitochondrial morphology | Q29615641 | ||
| Kinase activity is required for the toxic effects of mutant LRRK2/dardarin | Q29620478 | ||
| Localization and targeting of voltage-dependent ion channels in mammalian central neurons. | Q30492681 | ||
| Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases | Q31030866 | ||
| Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans | Q33225632 | ||
| The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation | Q33525587 | ||
| Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis | Q33595218 | ||
| Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease | Q33754793 | ||
| Alterations of cortical pyramidal neurons in mice lacking high-affinity nicotinic receptors | Q33953018 | ||
| LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease | Q34079774 | ||
| A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. | Q34165508 | ||
| DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy | Q34399382 | ||
| Genetics of Parkinson's disease: LRRK2 on the rise | Q34470633 | ||
| Mitophagy selectively degrades individual damaged mitochondria after photoirradiation | Q34806021 | ||
| Diversity in the regulation of autophagy and mitophagy: lessons from Parkinson's disease. | Q34985943 | ||
| LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans | Q35080550 | ||
| The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease | Q35607214 | ||
| Mitochondria: the next (neurode)generation | Q36124905 | ||
| Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation | Q36484737 | ||
| Calcium and neurodegeneration | Q36747495 | ||
| Imaging of mitochondrial polarization and depolarization with cationic fluorophores | Q36796225 | ||
| Visualization and quantification of mitochondrial dynamics in living animal cells. | Q36796290 | ||
| Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila | Q36891456 | ||
| Autophagy in neuroprotection and neurodegeneration: A question of balance. | Q36893822 | ||
| Progress in Parkinson's disease-where do we stand? | Q37200943 | ||
| Mitochondria in neuroplasticity and neurological disorders | Q37216404 | ||
| Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. | Q37408628 | ||
| Mitochondrial calcium function and dysfunction in the central nervous system | Q37418288 | ||
| Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration? | Q39834913 | ||
| Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy | Q41861209 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| P304 | page(s) | 474-484 | |
| P577 | publication date | 2012-12-08 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons | |
| P478 | volume | 182 |
| Q41075418 | 68 and FX2149 Attenuate Mutant LRRK2-R1441C-Induced Neural Transport Impairment |
| Q99711175 | A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2 |
| Q38211382 | A mitocentric view of Parkinson's disease. |
| Q26862840 | Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity |
| Q27026657 | After the banquet: mitochondrial biogenesis, mitophagy, and cell survival |
| Q38502057 | Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease |
| Q89729152 | Autophagy in Parkinson's Disease |
| Q37208557 | Autophagy in axonal and dendritic degeneration |
| Q34379744 | Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A |
| Q90263483 | Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration |
| Q38208179 | Calcium signaling in Parkinson's disease. |
| Q38433725 | Cellular processes associated with LRRK2 function and dysfunction |
| Q41889273 | Collapsin response mediator protein 5 (CRMP5) induces mitophagy, thereby regulating mitochondrion numbers in dendrites |
| Q42255446 | Connecting Ca2+ and lysosomes to Parkinson disease |
| Q47612330 | Convergent pathways in Parkinson's disease |
| Q38619109 | Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes |
| Q47611066 | Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons |
| Q38225786 | Defective autophagy in Parkinson's disease: lessons from genetics |
| Q40855302 | Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis |
| Q35912007 | Discovering New Genes in the Pathways of Common Sporadic Neurodegenerative Diseases: A Bioinformatics Approach |
| Q38125412 | Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease? |
| Q28071890 | Dysregulation of autophagy and mitochondrial function in Parkinson's disease |
| Q54987116 | ER-mitochondria signaling in Parkinson's disease. |
| Q47035955 | ER-mitochondria tethering by PDZD8 regulates Ca2+ dynamics in mammalian neurons |
| Q33593798 | ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease |
| Q58803405 | Excitatory Dendritic Mitochondrial Calcium Toxicity: Implications for Parkinson's and Other Neurodegenerative Diseases |
| Q46429920 | Exercise increases mitochondrial complex I activity and DRP1 expression in the brains of aged mice. |
| Q64763015 | Exploring the "Multiple-Hit Hypothesis" of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat. |
| Q47288069 | Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons. |
| Q41020334 | Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition. |
| Q28551962 | Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration |
| Q24310218 | Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily |
| Q38557027 | Genes associated with Parkinson's disease: regulation of autophagy and beyond |
| Q28396855 | Human Atg8-cardiolipin interactions in mitophagy: Specific properties of LC3B, GABARAPL2 and GABARAP |
| Q38104226 | Insights into mitochondrial quality control pathways and Parkinson's disease. |
| Q58604362 | Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations |
| Q27691411 | It's a cell-eat-cell world: autophagy and phagocytosis. |
| Q92173150 | LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same |
| Q42001785 | LRRK2 Regulates Voltage-Gated Calcium Channel Function |
| Q54976406 | LRRK2 and mitochondria: Recent advances and current views. |
| Q97066874 | LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease? |
| Q38689010 | LRRK2 at the Crossroad Between Autophagy and Microtubule Trafficking: Insights into Parkinson's Disease. |
| Q64769176 | LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10 |
| Q38218398 | LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis |
| Q36888947 | LRRK2: an éminence grise of Wnt-mediated neurogenesis? |
| Q37604377 | Leucine-Rich Repeat Kinase 2 (Lrrk2)-Sensitive Na+/K+ ATPase Activity in Dendritic Cells |
| Q35925767 | Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration |
| Q59332851 | MFF-dependent mitochondrial fission regulates presynaptic release and axon branching by limiting axonal mitochondria size |
| Q48239635 | Mechanisms of Mutant LRRK2 Neurodegeneration |
| Q61718173 | Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases. |
| Q36777303 | Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation. |
| Q37345733 | Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson's disease in Indian population |
| Q60923463 | Miro proteins prime mitochondria for Parkin translocation and mitophagy |
| Q38807556 | Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System |
| Q47147993 | Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease |
| Q47643867 | Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants |
| Q47653685 | Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease |
| Q92129107 | Mitophagy in Parkinson's Disease: From Pathogenesis to Treatment |
| Q38902595 | Modulation of Autophagy by Calcium Signalosome in Human Disease |
| Q36747314 | Molecular events underlying Parkinson's disease - an interwoven tapestry |
| Q52601351 | Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease. |
| Q34086842 | Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration |
| Q41427586 | NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease |
| Q38268886 | Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression |
| Q36379938 | Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation. |
| Q61454783 | Neurite Collapse and Altered ER Ca Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation |
| Q28075455 | Organelle-Specific Sensors for Monitoring Ca2+ Dynamics in Neurons |
| Q37375576 | Oxidative stress mechanisms underlying Parkinson's disease-associated neurodegeneration in C. elegans |
| Q38829987 | PKA Phosphorylation of NCLX Reverses Mitochondrial Calcium Overload and Depolarization, Promoting Survival of PINK1-Deficient Dopaminergic Neurons |
| Q89786852 | Parkinson's disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging |
| Q27308060 | Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice |
| Q55119593 | Protocols for assessing mitophagy in neuronal cell lines and primary neurons. |
| Q42008614 | Regulation of autophagy by LRRK2 in Caenorhabditis elegans |
| Q58708614 | Role of Mitochondrial Dysfunction in Degenerative Brain Diseases, an Overview |
| Q41882309 | Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis. |
| Q38160939 | Targeting leucine-rich repeat kinase 2 in Parkinson's disease |
| Q90564396 | The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach |
| Q36149449 | The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson's Disease |
| Q55442883 | The Enzymatic Core of the Parkinson’s Disease-Associated Protein LRRK2 Impairs Mitochondrial Biogenesis in Aging Yeast. |
| Q38202314 | The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease |
| Q38841508 | The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained |
| Q48232790 | Translational approaches to restoring mitochondrial function in Parkinson's disease. |
| Q36372732 | Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease |
| Q27026384 | Upstream deregulation of calcium signaling in Parkinson's disease |
Search more.